References
- Mahase E. Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction. British Medical Journal Publishing Group. 2020 Mar 12;368:m1036. doi:https://doi.org/10.1136/bmj.m1036.
- Wu Z, McGoogan JMJJ. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–42. doi:https://doi.org/10.1001/jama.2020.2648.
- Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan. China: a descriptive study 2020;395:507–13.
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan. China 2020;323:1061–69.
- Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2020;94:91–95.
- Mills KT, Stefanescu A, He J.The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–37. doi:https://doi.org/10.1038/s41581-019-0244-2.
- Gao C, Cai Y, Zhang K, Zhou L, Zhang Y, Zhang X, Li Q, Li W, Yang S, Zhao X, et al. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study. Eur Heart J. 2020;41(22):2058–66. doi:https://doi.org/10.1093/eurheartj/ehaa433.
- Li G, Am S, An J, Ning Y, Jd D, Ding L, Waintraub X, Wang J. Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality. Cardiol J. 2020;27(5):616–24. doi:https://doi.org/10.5603/CJ.a2020.0101.
- Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020;14:1753466620937175. doi:https://doi.org/10.1177/1753466620937175.
- Violi F, Cangemi R, Romiti GF, Ceccarelli G, Oliva A, Alessandri F, Pirro M, Pignatelli P, Lichtner M, Carraro A, et al. Is Albumin Predictor of Mortality in COVID-19? Antioxidants & redox signaling. 2020 Jun 22. doi: https://doi.org/10.1089/ars.2020.8142.
- Imai K, Okura H, Kume T, Yamada R, Miyamoto Y, Kawamoto T, Watanabe N, Neishi Y, Toyota E, Yoshida K, et al. C-Reactive protein predicts severity, progression, and prognosis of asymptomatic aortic valve stenosis. Am Heart J. 2008;156(4):713–18. doi:https://doi.org/10.1016/j.ahj.2008.04.011.
- Levitt DG, Levitt M. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med. 2016;9:229-55. https://doi.org/10.2147/IJGM.S102819
- Ranzani OT, Zampieri FG, Forte DN, Azevedo LC, Park M. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PloS one. 2013;8(3):e59321. doi:https://doi.org/10.1371/journal.pone.0059321.
- Llop-Talaveron J, Badia-Tahull MB, Leiva-Badosa E. An inflammation-based prognostic score, the C-reactive protein/albumin ratio predicts the morbidity and mortality of patients on parenteral nutrition. Clinical nutrition (Edinburgh, Scotland). 2018;37(5):1575–83. doi:https://doi.org/10.1016/j.clnu.2017.08.013.
- Lippi G, Wong J, Henry BM. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Polish archives of internal medicine. 2020;130(4):304–09. doi:https://doi.org/10.20452/pamw.15272.
- Bannaga AS, Tabuso M, Farrugia A, Chandrapalan S, Somal K, Lim VK, Mohamed S, Nia GJ, Mannath J, Wong JL, et al. C-reactive protein and albumin association with mortality of hospitalised SARS-CoV-2 patients: A tertiary hospital experience. Clinical medicine (London, England). 2020;20(5):463–67. doi:https://doi.org/10.7861/clinmed.2020-0424.
- De La Rica R, Borges M, Gonzalez-Freire MCOVID-19. In the Eye of the Cytokine Storm. Front Immunol. 2020;11:558898. doi:https://doi.org/10.3389/fimmu.2020.558898.
- Fairclough E, Cairns E, Hamilton J, Kelly C. Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome. Clin Med (Lond). 2009;9(1):30. doi:https://doi.org/10.7861/clinmedicine.9-1-30.
- Güney B, Taştan Y, Doğantekin B, Serindağ Z, Yeniçeri M, Çiçek V, Kılıç Ş, Şeker M, Çınar T, Hayiroglu Mİ, et al. Predictive value of CAR for In-Hospital Mortality in Patients with COVID-19 Pneumonia: A Retrospective Cohort Study. Arch Med Res. 2021. doi:https://doi.org/10.1016/j.arcmed.2021.02.006.
- Karakoyun I, Colak A, Turken M, Altin Z, Arslan FD, Iyilikci V, Yilmaz N, Kose S. Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients. Int Immunopharmacol. 2021;91:107285.
- Kim MH, Ahn JY, Song JE, Choi H, Ann HW, Kim JK, Kim JH, Jeon YD, Kim SB, Jeong SJ, et al. The C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Patients with Severe Sepsis or Septic Shock Treated with Early Goal-Directed Therapy. PloS one. 2015;10(7):e0132109. doi:https://doi.org/10.1371/journal.pone.0132109.
- Li N, Tian GW, Wang Y, Zhang H, Wang ZH, Li G. Prognostic Role of the Pretreatment C-Reactive Protein/Albumin Ratio in Solid Cancers: A Meta-Analysis. Sci Rep. 2017;7(1):41298. doi:https://doi.org/10.1038/srep41298.
- Yao Q, Wang P, Wang X, Qie G, Meng M, Tong X, Bai X, Ding M, Liu W, Liu K, et al. A retrospective study of risk factors for severe acute respiratory syndrome coronavirus 2 infections in hospitalized adult patients. Polish archives of internal medicine. 2020;130(5):390–99. doi:https://doi.org/10.20452/pamw.15312.
- Sun X, Wang T, Cai D, Hu Z, Chen J, Liao H, Zhi L, Wei H, Zhang Z, Qiu Y, et al. Cytokine storm intervention in the early stages of COVID-19 pneumonia. Cytokine Growth Factor Rev. 2020;53:38–42.
- Huang W, Li C, Wang Z, Wang H, Zhou N, Jiang J, Ni L, Zhang XA, Wang DW. Decreased serum albumin level indicates poor prognosis of COVID-19 patients: hepatic injury analysis from 2,623 hospitalized cases. Sci China Life Sci. 2020;63(11):1678–87. doi:https://doi.org/10.1007/s11427-020-1733-4.
- Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–43. doi:https://doi.org/10.1001/jamainternmed.2020.0994.
- Knaus WA, Draper EA, Wagner DP, Zimmerman JEAPACHEII.a severity of disease classification system. Crit Care Med. 1985;13(10):818–29. doi:https://doi.org/10.1097/00003246-198510000-00009.